Sanofi changes the structure of two business units

| By | Sanofi
0
199

Sanofi will change the organizational structure of two of its Global Business Units (GBU) to provide greater focus on its operations in mature markets and across emerging markets.

The company will create a new Primary Care GBU that combines the product portfolios of Sanofi’s existing Diabetes and Cardiovascular (DCV) GBU with Established Products, which are currently part of the General Medicines & Emerging Markets (GEM) GBU. The new Primary Care unit will focus exclusively on mature markets.

To help build and lead the new Primary Care business, Sanofi is appointing Dieter Weinand as Executive Vice President.

Sanofi is creating a second new global business unit called China & Emerging Markets to be led by Olivier Charmeil, currently head of the GEM GBU. This newly-formed business will focus on the unique characteristics and tremendous growth opportunities in emerging markets, particularly in China which is Sanofi’s second largest market after the United States.

Sanofi expects to launch the new Primary Care and China & Emerging Markets global business units by the beginning of 2019. Sanofi’s other GBUs-Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare-remain unchanged.

SOURCE: sanofi
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.